HighTower Advisors
MEDP icon

HighTower Advisors’s Medpace MEDP Stock Holding History

HighTower Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$204 – 3882
2024
Q2 		$204 Buy
+100
New +$39.6K ﹤0.01% 3617

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

HighTower Advisors's MEDP Position: Q2 2026 in Review

HighTower Advisors reduced its Medpace (MEDP) stake by 21% in Q2 2026, selling an estimated $454K and leaving 3,699 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

HighTower Advisors first reported a position in MEDP in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.42M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • HighTower Advisors held 3,699 shares of Medpace worth $1.96M as of Q2 2026.
  • HighTower Advisors sold 983 Medpace shares in Q2 2026, an estimated $454K.
  • Medpace made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1795 holding.
  • HighTower Advisors first reported a position in Medpace in Q3 2019 and has held it in 23 quarters since.
  • HighTower Advisors's Medpace position peaked at $3.42M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.